rs115480556
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001080463.2(DYNC2H1):c.12275G>A(p.Arg4092His) variant causes a missense change. The variant allele was found at a frequency of 0.00123 in 1,613,762 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R4092C) has been classified as Uncertain significance.
Frequency
Consequence
NM_001080463.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DYNC2H1 | NM_001080463.2 | c.12275G>A | p.Arg4092His | missense_variant | 85/90 | ENST00000650373.2 | |
DYNC2H1 | NM_001377.3 | c.12254G>A | p.Arg4085His | missense_variant | 84/89 | ENST00000375735.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DYNC2H1 | ENST00000650373.2 | c.12275G>A | p.Arg4092His | missense_variant | 85/90 | NM_001080463.2 | A1 | ||
DYNC2H1 | ENST00000375735.7 | c.12254G>A | p.Arg4085His | missense_variant | 84/89 | 1 | NM_001377.3 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00645 AC: 981AN: 152080Hom.: 13 Cov.: 31
GnomAD3 exomes AF: 0.00169 AC: 421AN: 248794Hom.: 10 AF XY: 0.00118 AC XY: 159AN XY: 134976
GnomAD4 exome AF: 0.000688 AC: 1006AN: 1461564Hom.: 13 Cov.: 31 AF XY: 0.000601 AC XY: 437AN XY: 727070
GnomAD4 genome AF: 0.00645 AC: 981AN: 152198Hom.: 13 Cov.: 31 AF XY: 0.00628 AC XY: 467AN XY: 74408
ClinVar
Submissions by phenotype
Jeune thoracic dystrophy Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Asphyxiating thoracic dystrophy 3 Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Sep 11, 2023 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 03, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at